These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14582439)

  • 21. Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure.
    Malfatto G; Facchini M; Branzi G; Riva B; Sala L; Perego GB
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):125-31. PubMed ID: 12827037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
    Cleland JG
    Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization.
    Schwarz ER; Gupta R; Diep TP; Nowak B; Kostin S; Grohmann B; Uretsky BF; Schaper J
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):181-90. PubMed ID: 16211207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 25. Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
    Bollano E; Täng MS; Hjalmarson A; Waagstein F; Andersson B
    Heart; 2003 Jun; 89(6):621-4. PubMed ID: 12748215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
    Hirooka K; Yasumura Y; Ishida Y; Hanatani A; Nakatani S; Komamura K; Hori M; Yamagishi M; Miyatake K
    Jpn Circ J; 2001 Nov; 65(11):931-6. PubMed ID: 11716241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.
    Kukin ML; Kalman J; Charney RH; Levy DK; Buchholz-Varley C; Ocampo ON; Eng C
    Circulation; 1999 May; 99(20):2645-51. PubMed ID: 10338457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.
    Bristow MR; Gilbert EM; Abraham WT; Adams KF; Fowler MB; Hershberger RE; Kubo SH; Narahara KA; Ingersoll H; Krueger S; Young S; Shusterman N
    Circulation; 1996 Dec; 94(11):2807-16. PubMed ID: 8941106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does beta-blocker treatment influence central sleep apnoea?
    Köhnlein T; Welte T
    Respir Med; 2007 Apr; 101(4):850-3. PubMed ID: 17223328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure.
    Maurer MS; Sackner-Bernstein JD; El-Khoury Rumbarger L; Yushak M; King DL; Burkhoff D
    Circ Heart Fail; 2009 May; 2(3):189-96. PubMed ID: 19808339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
    Kohno T; Yoshikawa T; Yoshizawa A; Nakamura I; Anzai T; Satoh T; Ogawa S
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):347-55. PubMed ID: 16382297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy.
    Piccirillo G; Quaglione R; Nocco M; Naso C; Moisè A; Lionetti M; Di Carlo S; Marigliano V
    Am J Cardiol; 2002 Nov; 90(10):1113-7. PubMed ID: 12423713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effects of beta-adrenoblocker therapy on the physical working capacity of patients with chronic heart failure of various origin].
    Poltavskaia MG; Syrkin AL; Andreev DA; Svet AV; Sarkisova EA; Kalashnikov VIu
    Klin Med (Mosk); 2007; 85(5):37-41. PubMed ID: 17665602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
    Wei S; Chow LT; Sanderson JE
    J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
    Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.